PT Phapros Tbk (PEHA.JK)
Jakarta · IDR · Healthcare · Drug Manufacturers - Specialty & Generic
IDR 266 (-0.75%) as of
Key statistics
- Market cap
- 223.44B
- P/E (TTM)
- 5.54
- EPS (TTM)
- 48.00
- Dividend yield
- 1.87%
- 52-week range
- 206.00 – 460.00
- Beta
- 0.40
- Revenue (TTM)
- 965.5B
- Profit margin
- 4.24%
- Volume
- 14.30k
About PT Phapros Tbk
PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Jakarta Selatan, Indonesia
- Employees
- 1,255
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.